Mednax Inc Stock Market Value
| MD Stock | USD 21.07 0.40 1.86% |
| Symbol | Mednax |
Will Health Care Providers & Services sector continue expanding? Could Mednax diversify its offerings? Factors like these will boost the valuation of Mednax. Expected growth trajectory for Mednax significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mednax data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 2.652 | Earnings Share 1.91 | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets |
Understanding Mednax Inc requires distinguishing between market price and book value, where the latter reflects Mednax's accounting equity. The concept of intrinsic value - what Mednax's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Mednax's price substantially above or below its fundamental value.
Understanding that Mednax's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mednax represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Mednax's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Mednax 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mednax's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mednax.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Mednax on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Mednax Inc or generate 0.0% return on investment in Mednax over 90 days. Mednax is related to or competes with National HealthCare, Select Medical, Acadia Healthcare, Astrana Health, Aveanna Healthcare, Ardent Health, and Lifestance Health. Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, a... More
Mednax Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mednax's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mednax Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 7.73 | |||
| Value At Risk | (3.57) | |||
| Potential Upside | 2.95 |
Mednax Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mednax's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mednax's standard deviation. In reality, there are many statistical measures that can use Mednax historical prices to predict the future Mednax's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.19) | |||
| Treynor Ratio | (0.74) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mednax's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Mednax February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.73) | |||
| Mean Deviation | 1.44 | |||
| Coefficient Of Variation | (4,180) | |||
| Standard Deviation | 1.84 | |||
| Variance | 3.37 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.19) | |||
| Treynor Ratio | (0.74) | |||
| Maximum Drawdown | 7.73 | |||
| Value At Risk | (3.57) | |||
| Potential Upside | 2.95 | |||
| Skewness | (0.25) | |||
| Kurtosis | (0.25) |
Mednax Inc Backtested Returns
Mednax Inc has Sharpe Ratio of -0.0499, which conveys that the firm had a -0.0499 % return per unit of risk over the last 3 months. Mednax exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mednax's Risk Adjusted Performance of (0.01), mean deviation of 1.44, and Standard Deviation of 1.84 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.0731, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Mednax's returns are expected to increase less than the market. However, during the bear market, the loss of holding Mednax is expected to be smaller as well. At this point, Mednax Inc has a negative expected return of -0.0932%. Please make sure to verify Mednax's potential upside, and the relationship between the total risk alpha and daily balance of power , to decide if Mednax Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.56 |
Modest predictability
Mednax Inc has modest predictability. Overlapping area represents the amount of predictability between Mednax time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mednax Inc price movement. The serial correlation of 0.56 indicates that roughly 56.0% of current Mednax price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.56 | |
| Spearman Rank Test | 0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 0.36 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Mednax Correlation, Mednax Volatility and Mednax Performance module to complement your research on Mednax. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Mednax technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.